Nidek makes progress with second stab at US laser market hyperopia
This article was originally published in Clinica
Executive Summary
Nidek is steaming ahead with its second attempt to take its excimer laser to the US hyperopia market. It has submitted to the FDA three-month data from a clinical study of an upgraded version of its EC-5000 excimer laser that incorporates new software and algorithms.